Abstract: Neurodegeneration, the progressive death of neurons, loss of brain function, and cognitive decline is an increasing problem for senior populations. Its causes are poorly understood and therapies are largely ineffective. Neurons, with high energy and oxygen requirements, are especially vulnerable to detrimental factors, including age-related dysregulation of biochemical pathways caused by altered expression of multiple genes. GHK (glycyl-L-histidyl-L-lysine) is a human copper-binding peptide with biological actions that appear to counter aging-associated diseases and conditions. GHK, which declines with age, has health promoting effects on many tissues such as chondrocytes, liver cells and human fibroblasts, improves wound healing and tissue regeneration (skin, hair follicles, stomach and intestinal linings, boney tissue), increases collagen, decorin, angiogenesis, and nerve outgrowth, possesses anti-oxidant, anti-inflammatory, anti-pain and anti-anxiety effects, increases cellular stemness and the secretion of trophic factors by mesenchymal stem cells. Studies using the Broad Institute Connectivity Map show that GHK peptide modulates expression of multiple genes, resetting pathological gene expression patterns back to health. GHK has been recommended as a treatment for metastatic cancer, Chronic Obstructive Lung Disease, inflammation, acute lung injury, activating stem cells, pain, and anxiety. Here, we present GHK's effects on gene expression relevant to the nervous system health and function.
Introduction
Age-related cognitive decline is a common problem for many elderly people, yet its cause is poorly understood. Over 99% of investigational drugs, participating in over 200 clinical trials, failed to receive approval for the treatment of Alzheimer's disease [1] . Even the success of a few approved drugs provides only minimal patient improvement. There is a need for new, safe, and effective therapeutics with extensive safety and efficacy data that can be developed for use in humans within the next few years.
GHK (glycyl-L-histidyl-L-lysine) is a human plasma copper-binding peptide with a stunning array of actions that appear to counter aging-associated diseases and conditions. GHK was isolated in 1973 as an activity bound to human albumin that caused aged human liver tissue to synthesize proteins like younger tissue [2] . It has a strong affinity for copper and readily forms the complex GHK-Cu. It was first proposed that GHK-Cu functions by modulating copper intake into cells [3] . Since then, it has been established that the GHK peptide has stimulating and growth-promoting effects on many cells and tissues such as chondrocytes [4] , liver cells and human fibroblasts [5] . It increases Lindner and colleagues found that explants from chick embryo PNS (ganglion trigeminale) and from CNS of embryonal rats (hippocampus) and dissociated cells from chick embryo cerebral hemispheres that 0.01 microgram GHK per ml of medium stimulated the outgrowth of neuronal processes. Again, GHK promoted neuronal growth but not glial cells [23] .
In studies of rats, severed sciatic nerves (axotomy) were inserted into a collagen prosthesis to which GHK was bonded. These were re-inserted into the rat, then removed after 10 days. GHK enhanced the production of trophic factors (Nerve Growth Factor, Neurotrophins 3 and 4) and recruited hematogenous cells and Schwann cells, which in turn help in the secretion of certain vital trophic and tropic factors essential for early regeneration. This improved nerve regeneration following axotomy [24] . Surprisingly, GHK's gene expression data gives suppression of NGF (−243%) and NGFR (nerve growth factor receptor) (−132%). Thus, the biological system within wounded rat's nervous tissue is more complex and probably due to other nerve stimulatory molecules. Lindner and colleagues found that explants from chick embryo PNS (ganglion trigeminale) and from CNS of embryonal rats (hippocampus) and dissociated cells from chick embryo cerebral hemispheres that 0.01 microgram GHK per ml of medium stimulated the outgrowth of neuronal processes. Again, GHK promoted neuronal growth but not glial cells [23] .
In studies of rats, severed sciatic nerves (axotomy) were inserted into a collagen prosthesis to which GHK was bonded. These were re-inserted into the rat, then removed after 10 days. GHK enhanced the production of trophic factors (Nerve Growth Factor, Neurotrophins 3 and 4) and recruited hematogenous cells and Schwann cells, which in turn help in the secretion of certain vital trophic and tropic factors essential for early regeneration. This improved nerve regeneration following axotomy [24] . Surprisingly, GHK's gene expression data gives suppression of NGF (−243%) and NGFR (nerve growth factor receptor) (−132%). Thus, the biological system within wounded rat's nervous tissue is more complex and probably due to other nerve stimulatory molecules.
Copper Deficiency, Dementia, and Nerve Dysfunction
Copper is an essential component of important anti-oxidant proteins such as SOD (copper zinc superoxide dismutase), ceruloplasmin, and Atox1 (human antioxidant protein 1). Copper deficiency has been postulated as a causative factor in a variety of gene diseases such as Alzheimer's [25] [26] [27] [28] [29] [30] , myelopathy [31] , motor neuron diseases and amyotrophic lateral sclerosis [32] , Huntington's [33] , Lewy bodies and Creutzfeldt Jakob diseases [34] .
More importantly, analysis of actual human brains from deceased patients with dementia has found the damaged areas to have very little cellular copper. In plaques from persons with Alzheimer's disease, iron and aluminum appear to cause plaque formation while copper and zinc may be protective [26] [27] [28] [35] [36] [37] .
Copper deficiency caused by bariatric surgery or gastrointestinal bleeding led to myelopathy (human swayback), paralysis, blindness and behavioral and cognitive changes. Mice born and maintained on a copper deficient diet had 80% reduction in brain copper level at 6-8 weeks and had neuronal and glial changes typical for neurodegenerative disorders [25, 31, 38, 39] .
Supplying Copper to Nerve Cells
Though copper deficiency appears linked to major nerve diseases, the use of copper supplements as a treatment has been disappointing. A placebo-controlled study of 68 Alzheimer's patients (34 control, 34 copper) with a treatment of 8 mgs of daily copper (a high level) for 1 year produced no negative findings. This seems to rule out excessive copper levels as a causative agent for the development of Alzheimer's. The predictive protein marker, CSF Abeta42, is lower in persons developing Alzheimer's. Subjects given extra copper supplementation maintained this protein at a higher level, a possible positive effect, but there was minimal improvement in the disease [40] .
One small copper complex chelator, CuATSM (diacetyl-bis(4-methylthiosemicarbazonato)copper 2+), has given indications of ameliorating the effects of ALS (familial amyotrophic lateral sclerosis) in a strain of genetically modified mice that develop a form of ALS. CuATSM extends life in such mice by up to 25%. The motor neuron disease can be restarted and then stopped by controlling CuATSM treatment. The treatment increases the amount of active superoxide dismutase in the mice [41] . The safety of CuATSM is largely unknown. The safety data sheet states the following: "Material may be irritating to the mucous membranes and upper respiratory tract. May be harmful by inhalation, ingestion, or skin absorption. May cause eye, skin, or respiratory system irritation. To the best of our knowledge, the toxicological properties have not been thoroughly investigated." GHK-Copper 2+ increased superoxide dismutase (SOD) activity in mice as detailed below in Section 4 [42] .
Albumin, GHK and Copper Transport
Both albumin and GHK transport copper 2+ to cells and tissues. However, in human blood, there are 700 albumin molecules for each GHK molecule, so albumin is the major source of copper for tissue use. GHK and albumin have high and very similar binding constants for copper 2+ (Albumin = pK binding log 10 |16.2|; GHK = pK binding log 10 |16.4|). Human plasma contains about 15 micromolar copper and 12% (1.8 micromolar) of this is bound to albumin. But GHK-Cu is maximally active on most cells around one nanomolar or less. Aqueous dialysis studies established that GHK can obtain copper 2+ from albumin. We assume that this also occurs in cell culture and within mammals and that GHK has adequate copper for biological actions.
Our studies over the past 39 years have indicated that virtually all biological GHK effects require the presence of copper 2+ chelated to the tripeptide. Strong copper chelators such as bathocuproine abolish GHK actions. GHK alone is often effective in murine wound healing or hair growth models, but GHK-Cu always produced much stronger responses. GHK attached to radioactive copper-64 increases copper uptake into cultured hepatoma cells [7] .
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The intravenous injection of tritiated copper-free GHK into mice was found, after 4 h, to concentrate most densely within the animals' kidneys and brain. See Figure 2 [43] .
The best evidence that GHK can obtain copper 2+ from body fluids was from a study that used biotinylated GHK bound to collagen films placed over wounds in rats. The GHK pads raised the copper concentration by ninefold at the wound site when compared to non-GHK collagen films. Such biotinylated GHK collagen films also increased wound healing, cell proliferation, and increased the expression of antioxidant enzymes in the treated group [9] .
Most importantly, GHK activates numerous regenerative and protective genes. Albumin will not mimic the GHK activated systems. So GHK must act through a separate pathway, not the albumin pathway. Albumin's copper feeds cells; GHK's copper activates regenerative and protective genes. GHK-Cu's regenerative and protective actions on tissue are very similar to those found by John R Sorenson throughout his 33 years of work on various copper salicylates. See Table 1 . It appears that GHK-Copper and Sorenson's DIPS-Cu (diisopropylsalicylate-copper 2+) both activate the same pathway, a pathway strongly associated with tissue health and repair. GHK-copper 2+ (molecular weight 404) and Sorenson's DIPS-Cu (molecular weight 506) are both very small molecules while albumin is much larger (molecular weight 64,000). Hence, they are likely to use different cell receptor systems [44] [45] [46] [47] [48] [49] . See Figure 3 . The best evidence that GHK can obtain copper 2+ from body fluids was from a study that used biotinylated GHK bound to collagen films placed over wounds in rats. The GHK pads raised the copper concentration by ninefold at the wound site when compared to non-GHK collagen films. Such biotinylated GHK collagen films also increased wound healing, cell proliferation, and increased the expression of antioxidant enzymes in the treated group [9] .
Most importantly, GHK activates numerous regenerative and protective genes. Albumin will not mimic the GHK activated systems. So GHK must act through a separate pathway, not the albumin pathway. Albumin's copper feeds cells; GHK's copper activates regenerative and protective genes.
GHK-Cu's regenerative and protective actions on tissue are very similar to those found by John R Sorenson throughout his 33 years of work on various copper salicylates. See Table 1 . It appears that GHK-Copper and Sorenson's DIPS-Cu (diisopropylsalicylate-copper 2+) both activate the same pathway, a pathway strongly associated with tissue health and repair. GHK-copper 2+ (molecular weight 404) and Sorenson's DIPS-Cu (molecular weight 506) are both very small molecules while albumin is much larger (molecular weight 64,000). Hence, they are likely to use different cell receptor systems [44] [45] [46] [47] [48] [49] . See Figure 3 . 
Anti-Anxiety (Anxiolytic) and Anti-Pain
Anxiety and pain are serious issues in patients with dementia and other disabling mental conditions. Opiate peptides often possess both anti-pain and wound healing properties [50] . When healthy human males were fed a low copper diet (1 mg/day of copper) for 11 weeks, their plasma opiate levels dropped by 80%. As soon as copper was restored (with a diet containing 3 mg/day of copper), the levels returned to normal [51] .
GHK has been found to possess analgesic and anxiolytic effects (anti-anxiety) in animal experiments. GHK reduced pain after thermal injury to rats at a dose of 0.5 milligrams/kg. Within 12 min after intraperitoneal injection, it also increased the amount of time the rats spent exploring more open areas of the maze and decreased time spent immobile (the freeze reaction), which indicated reduction of fear and anxiety. These effects were observed at 0.5 micrograms/kg [52, 53] .
These effects also prove that GHK rapidly affects the brain perception and function. This is an area where GHK could be used on patients today.
A manual search of genes affected by GHK found that seven anti-pain genes increased and two genes decreased. See Tables 2 and 3 . 
Percent Change in Gene Expression
Genes UP Genes DOWN 50%-99%  0  0  100%-199%  5  2  200%-299%  1  0  300%-399%  0  0  400%-499%  0  0  500%+  1  0  Total  7  2 Figure 3. Proposed cell receptor for GHK-Cu.
Anti-Anxiety (Anxiolytic) and Anti-Pain
A manual search of genes affected by GHK found that seven anti-pain genes increased and two genes decreased. See Tables 2 and 3 . Table 2 . Distribution of Genes Affected by GHK and Associated with Pain.
Percent Change in Gene Expression
Genes UP Genes DOWN 
Antioxidant Activity of the GHK Peptide
High metabolic activity found in the brains of both humans and animals results in elevated oxygen consumption and constant production of reactive oxygen species (ROS) in mitochondria. At the same time, the brain tissue is rich in unsaturated fatty acids and transition metal ions, yet has relatively fewer antioxidants compared to other organs, creating favorable conditions for oxidative damage. Since the blood-brain barrier prevents many dietary antioxidants from entering the brain, it largely relays on endogenous antioxidants such as Cu and Zn dependent superoxide dismutase (Cu, Zn SOD1). This enzyme requires the metal ions copper and zinc in order to be active. Hence, copper deficiency can lead to reduced SOD activity and increased oxidative brain damage. When pregnant rats were fed a copper deficient diet, the embryos displayed low SOD activity, increased super oxide anion radical level, and higher incidence of DNA damage and malformations [54] .
GHK has broad and powerful anti-oxidation properties in both mammals and cell culture, and it is known to increase anti-oxidant gene expression. Tissue oxidation has been postulated as a causative factor in Parkinson's disease and other various nerve diseases of aging [55] [56] [57] [58] [59] .
Diminished copper has been found in cells expressing SOD1 mutations postulated to cause ALS in mice and increase memory loss [60, 61] .
A peptidomimetic inhibitor (P6), based on GHK, interacts with amyloid beta (Aβ) peptide and its aggregates. P6 prevents the formation of toxic Aβ oligomeric species, fibrillar aggregates and DNA damage. It is a potential therapeutic candidate to ameliorate the multifaceted Aβ toxicity in Alzheimer's [62] .
GHK's Anti-Oxidant Effects in Mammals and Cell Culture
The use of GHK-Cu in mice protected their lung tissue from lipopolysaccharide-induced acute lung injury (ALI). When GHK-Cu was used by mice with LPS-induced ALI, it attenuated related histological alterations in the lungs and suppressed the infiltration of inflammatory cells into the lung parenchyma. The GHK-Cu also increased superoxide dismutase (SOD) activity while decreasing TNF-α and IL-6 production through the suppression of the phosphorylation of NF-κB p65 and p38 MAPK in the nucleus of lung cells [42] .
P38 mitogen-activated protein kinases are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in cell differentiation, apoptosis, and autophagy. NF-κB/RELA p65 activation has been found to be correlated with cancer development, Brain Sci. 2017, 7, 20 9 of 37 suggesting the potential of RELA as a cancer biomarker. Specific modification patterns of RELA have also been observed in many cancer types.
Multiple antioxidant actions of GHK have been demonstrated in vitro and in animal wound healing studies. They include inhibiting the formation of reactive carbonyl species (RCS), detoxifying toxic products of lipid peroxidation such as acrolein, protecting keratinocytes from lethal UVB radiation, and preventing hepatic damage by dichloromethane radicals.
The ability of GHK to prevent oxidative stress was tested in vitro using Cu(2+)-dependent oxidation of low-density lipoproteins (LDL). LDL were treated with 5 µM Cu(2+) for 18 h in either phosphate buffered saline (PBS) or Ham's F-10 medium. There was increased production of thiobarbituric acid reactive substances (TBARSs), which indicated increased oxidation. GHK and histidine "entirely blocked" (quoted from the article) the in vitro Cu(2+)-dependent oxidation of low-density lipoproteins (LDL). In comparison, superoxide dismutase (SOD1) provided only 20% reduction of oxidation [63] .
Acrolein, a well-known carbonyl toxin, is produced by lipid peroxidation of polyunsaturated fatty acids. GHK effectively reduces the formation of both acrolein and another product of oxidation, 4-hydroxynonenal. GHK also blocks lethal ultraviolet radiation damage to cultured skin keratinocytes by binding and inactivating reactive carbonyl species such as 4-hydroxynoneal, acrolein, malondialdehyde, and glyoxal [64] [65] [66] .
The intraperitoneal injection of 1.5 mg/kg of GHK into rats for five days before dichloromethane poisoning and five days thereafter provided protection of the functional activity of hepatocytes and immunological responsiveness. Dichloromethane is toxic to hepatic tissue via the formation of a dichloromethane free radical that induces acute toxic damage [67] .
In rats with experimental bone fractures peptides, GHK (0.5 µg/kg), dalargin (1.2 µg/kg), and thymogen (0.5 µg/kg) were injected intraperitoneally. Within 10 days, there was a decrease of malonic dialdehyde and an increase of catalase activity in blood. There was also a marked increase of reparative activity. Each combination of peptides was more potent than any of the studied peptides injected separately. The synergetic action of peptides Gly-His-Lys, thymogen, and dalargin was proposed for stimulation of reparative osteogenesis [68] .
GHK-Cu reduced iron release from ferritin by 87%. Iron has also been shown to have a direct role in the initiation of lipid peroxidation. An Fe(2+)/Fe(3+) complex can serve as an initiator of lipid oxidation. In addition, many iron complexes can catalyze the decomposition of lipid hydroperoxides to the corresponding lipid alkoxy radicals. The major storage site for iron in serum and tissue is ferritin. Ferritin in blood plasma can store up to 4500 atoms of iron per protein molecule, and superoxide anions can promote the mobilization of iron from ferritin. This free iron may then catalyze lipid peroxidation and the conversion of a superoxide anion to the more damaging hydroxyl radical [69] .
Synthesis of GHK-Cu Analogs with Higher Anti-ROS Activity
GHK-Cu has, on a molar basis, about 1% to 3% of the activity of the Cu, Zn superoxide dismutase protein. By simple modifications to the peptide, it is possible to raise the SOD-mimetic activity up 223-fold. Given the broad range of the antioxidant actions of GHK, it is likely that modifications will increase its countering reactive species such as RCS and dichloromethane radicals. See Table 4 [70] . Table 4 . Superoxide Dismutase Mimetic Activity of GHK and Analogs.
Molecule Superoxide Dismutase Mimetic Activity
Gly-His-Lys:Cu(2+) 100 Lys-His-Gly-Amide:Cu(2+) 21 Gly-His-Lys-Ala-Phe-Ala:Cu(2+) 561 Ala-His-Lys:Cu(2+) 563 Gly-His-Lys-Octyl Ester:Cu(2+) 810 Gly-His-Caprolactam:Cu(2+) 4500 His-Gly-Lys:Cu(2+) 22,300
Antioxidant Gene Expression Analysis
A manual search of antioxidant associated genes effected by GHK yielded 18 genes with significant antioxidant activity. See Tables 5 and 6 . Table 5 . Distribution of Genes Affected by GHK with Antioxidant Activity.
Percent Change in Gene Expression
Genes UP Genes DOWN Table 6 . GHK and Genes Associate with Antioxidant Activity.
UP Genes Percent Change in Gene Expression Comments
Inhibits the oxidative/inflammatory gene NF-κB [71] .
SPRR2C 721
This proline-rich, antioxidant protein protects outer skin cells from oxidative damage from reactive oxygen species (ROS). When the ROS level is low, the protein remains in the outer cell membrane, but when the ROS level is high, the protein clusters around the cell's DNA to protect it [72, 73] .
Up-regulation of ITGB4 promotes wound repair ability and antioxidative ability [74] .
Binds oxidized phospholipids and increases the antioxidant effect of high-density lipoproteins (HDL) [75] .
PON3 319
Absence of PON3 (paraoxonase 3) in mice resulted in increased rates of early fetal and neonatal death. Knockdown of PON3 in human cells reduced cell proliferation and total antioxidant capacity [76] .
IL18BP 295
The protein encoded by this gene is an inhibitor of the pro-inflammatory cytokine IL18. IL18BP abolished IL18 induction of interferon-gamma (IFN gamma), IL8, and activation of NF-κB in vitro. Blocks neutrophil oxidase activity [77] .
HEPH 217
Inhibits the conversion of Fe(2+) to Fe(3+). HEPH increases iron efflux, lowers cellular iron levels, suppresses reactive oxygen species production, and restores mitochondrial transmembrane potential [78] .
Acts as a direct negative regulator of NLRP3. NLRP3 triggers the maturation of the pro-inflammatory cytokines IL-1β and IL-18 [79] .
Reduces intracellular ROS level. Plays a significant role in reduction of oxidative stress [80, 81] .
AGTR2 171
AGTR2 exerts an anti-inflammatory response in macrophages via enhanced IL-10 production and ERK1/2 phosphorylation, which may have protective roles in hypertension and associated tissue injury [82] .
11 PON1 149 PON1 (paraoxonase 1) is a potent antioxidant and a major anti-atherosclerotic component of HDL [83] .
MT3 142
Metallothioneins (MTs) display in vitro free radical scavenging capacity, suggesting that they may specifically neutralize hydroxyl radicals. Metallothioneins and metallothionein-like proteins isolated from mouse brain act as neuroprotective agents by scavenging superoxide radicals [84, 85] .
Produces cyclooxygenase-II (COX-II), which has antioxidant activities [86] .
SLC2A9 117
The p53-SLC2A9 pathway is a novel antioxidant mechanism. During oxidative stress, SLC2A9 undergoes p53-dependent induction, and functions as an antioxidant by suppressing ROS, DNA damage, and cell death [87] .
DOWN Genes Percent Change in Gene Expression Comments
This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis, and multiple sclerosis ([88]).
2 TNF −115 GHK suppresses this pro-oxidant TNF gene [89] .
DNA Repair, Cell Culture, and Gene Expression
A lack of adequate DNA repair may be related to neurological degeneration in the aging population [90] [91] [92] [93] .
DNA damage is a major problem in the life cycle of biological cells. Normal cellular metabolism releases compounds that damage DNA such as reactive oxygen species, reactive nitrogen species, reactive carbonyl species, lipid peroxidation products and alkylating agents, among others, while hydrolysis cleaves chemical bonds in DNA. It is estimated that each normally functioning cell in the human body suffers at least 10,000 DNA damaging incidents daily [94] .
Radiation therapy is believed to stop cell replication by damaging cellular DNA. A study of cultured primary human dermal fibroblast cell lines from patients who had undergone radiation therapy for head and neck cancer found that the procedure slowed the population doubling times for the cells. But treatment with one nanomolar GHK-Cu restored population doubling times to normal. Irradiated cells treated with GHK-Cu also produced significantly more basic fibroblast growth factor and vascular endothelial growth factor than untreated irradiated cells [5] .
GHK is primarily stimulatory for gene expression of DNA Repair genes (47 UP, 5 DOWN), suggesting an increased DNA repair activity. Here we searched the Gene Ontology descriptions for "DNA Repair". See Tables 7 and 8 . Table 7 . Distribution of Genes Affected by GHK and Associated with DNA Repair.
Percent Change in Gene Expression
Restoring Regeneration After Cortisone Treatment
Steroid dementia syndrome describes the signs and symptoms of hippocampal and prefrontal cortical dysfunction, such as deficits in memory, attention, and executive function, induced by glucocorticoids. Dementia-like symptoms have been found in some individuals who have been exposed to glucocorticoid medication, often dispensed in the form of asthma, arthritis, and anti-inflammatory steroid medications. The condition reverses, but not always completely, within months after steroid treatment is stopped [95] .
In the human body, cortisone and cortisol are easily interconvertible and have similar anti-inflammatory actions. They also profoundly inhibit tissue regeneration, such as wound repair. DHEA (dehydroepiandrosterone) is an androgenic hormone. It is a precursor for testosterone and the estrogens. DHEA antagonizes the effects of cortisol but decreases about 80% from age 20 to age 80 while cortisone/cortisol levels remain high. It has been proposed that many of the deleterious effects of aging are due to excessive cortisol that is not balanced by DHEA.
GHK-Cu, when administered systemically to mice, rats, and pigs, counters the wound healing inhibition of cortisone throughout the animal [96] .
Gene Expression-Clearing Damaged Protein-Ubiquitin Proteasome System
The ubiquitin proteasome system (UPS) clears damaged proteins. Insufficient activity of this system is postulated to produce an accumulation of toxic protein oligomers which start the neurodegenerative process. During aging, there is decreased activity of the ubiquitin proteasome system. To date, no effective therapies have been developed that can specifically increase the UPS activity [97] [98] [99] [100] .
GHK strongly stimulates the gene expression of the UPS system with 41 genes increased and 1 gene suppressed. Here we searched gene title for "ubiquitin" or "proteasome". See Tables 9 and 10 . Table 9 . Distribution of Genes Affected by GHK and Associated with the Ubiquitin Proteasome System.
Percent Change in Gene Expression
Gene Expression-Neurons
Neurons are cells that carry messages between the brain and other parts of the body; they are the basic units of the nervous system. GHK is primarily stimulatory for gene expression of neuron related genes. Here we searched the Gene Ontology descriptions for "Neuron". See Tables 11 and 12 . 
Motor Neurons
Motor neurons are nerve cells forming part of a pathway along which impulses pass from the brain or spinal cord to a muscle or gland.
Here we searched Gene Ontology descriptions for "motor neuron". See Tables 13 and 14 . 
Gene Expression-Glial Cells
Glial cells are non-neuronal cells that maintain homeostasis, form myelin, and provide support and protection for neurons in the central and peripheral nervous systems.
Here we searched Gene Ontology descriptions for "glial". See Tables 15 and 16 . 
Astrocyte
Astrocytes are characteristic star-shaped glial cells in the brain and spinal cord. The astrocyte proportion varies by region and ranges from 20% to 40% of all glial cells. They perform many functions, including biochemical support of endothelial cells that form the blood-brain barrier, provision of nutrients to the nervous tissue, maintenance of extracellular ion balance, and a role in the repair and scarring process of the brain and spinal cord following traumatic injuries.
Here we searched Gene Ontology descriptions for "astrocyte". See Tables 17 and 18 . 
Percent Change in Gene Expression
Genes UP Genes DOWN 50%-99%  8  3  100%-199%  5  2  200%-299%  2  1  300%-399%  0  0  400%-499%  0  0  500%+  0  0  Total  15  6   Table 18 . GHK and Genes Associated with Astrocytes. 
UP

Schwann Cells
Schwann cells are cells of the peripheral nervous system that wrap around a nerve fiber, jelly-roll fashion, forming the myelin sheath.
Here we searched Gene Ontology descriptions for "Schwann". See Tables 19 and 20 . Table 19 . Distribution of Genes Affected by GHK and Associated with Schwann Cells.
Percent Change in Gene Expression
Myelin
Myelin is a mixture of proteins and phospholipids that form a whitish insulating sheath around many nerve fibers, increasing the speed at which impulses are conducted.
Here we searched Gene Ontology descriptions for "myelin". See Tables 21 and 22 . 
Gene Expression-Dendrites
Dendrites are short branched extensions of a nerve cell, along which impulses received from other cells at synapses are transmitted to the cell body.
Here we searched Gene Ontology descriptions for "dendrite". See Tables 23 and 24 . 
Gene Expression-Oligodendrocytes
Oligodendrocytes are glial cells similar to astrocytes, but with fewer protuberances, which are concerned with the production of myelin in the central nervous system.
Here we searched Gene Ontology descriptions for "oligodendrocyte". See Tables 25 and 26 . 
Gene Expression-Sensory Nerve cells
Sensory neurons are nerves that transmit sensory information (sight, sound, feeling, etc.). They are activated by sensory input and send projections to other elements of the nervous system, ultimately conveying sensory information to the brain or spinal cord.
Here we searched Gene Ontology descriptions for "sensory". See Tables 27 and 28 . 
Spinal Nerve Cells
Spinal nerve cells transfer information, which travels down the spinal cord, as a conduit for sensory information in the reverse direction, and finally as a center for coordinating certain reflexes.
Here we searched Gene Ontology descriptions for "spinal". See Tables 29 and 30 . GHK-Cu has an unexpectedly rapid passage through skin's stratum corneum. When tested by Howard Maibach's group (Univerisity of California at San Francisco), 0.68% GHK-Cu was applied to dermatomed skin. Over 48 h, 136 micrograms of GHK-Cu passed through the skin per centimeter squared. This is a significant amount of GHK-Cu, and a transdermal patch of a several centimeters squared may pass therapeutically effective amounts throughout the human body [101] .
Russian studies reported that 0.5 micrograms/kg reduced anxiety in rats. Scaled up for a human weight of 70 kg, this would be 35 micrograms in a human [52] . Our studies on activation of systemic healing in mice, rats, and pigs suggest that about 50 milligrams of GHK-Cu would be effective throughout the human body, although dose-ranging to determine the minimum active dosage was never performed.
Liposomal Encapsulated Oral Tablet
Alternately, the use of encapsulated liposomal GHK-Cu would allow its oral administration at relatively high dosages. Some sellers of an encapsulated liposomal tripeptide glutathione claim that 60% of the orally administrated peptide enters the human blood stream [102] . Direct administration in a regular pill form is unlikely to work because of GHK's extreme sensitivity to breakdown by intestinal carboxypeptidase [103] .
GHK-Cu costs about $8/gram in kilogram amounts. For a 50 mg dosage, the GHK-Cu would cost about $0.40. It is possible that GHK alone would be effective in humans and be able to obtain sufficient amounts of copper 2+ from albumin. If so, this would simplify its therapeutic use. The minimum effective dosage of GHK-Cu for various uses is unknown since such studies were never performed.
GHK-Cu does lower blood pressure, but the LD50 (Lethal Dose for 50% of mice) for such effects would be about a single dosage of 23,000 mgs of GHK-Cu in a 70 kg human. In GHK-Cu's long history of use in cosmetics, no health issues have ever arisen. We were never able to find an LD 50 for GHK without copper.
In our studies, equimolar mixtures of GHK-Cu and GHK (no copper) are often used to avoid any release of loosely bound copper. Also, copper chelators such as penicillamine have been reported to cause psychosis in humans [104] .
Conclusions
Given all the failed attempts to develop effective treatment methods for nerve degeneration, it is suggested that researchers must take a very broad view of the possible factors causing neurodegenerative diseases and not focus on limited possible causes. It is sensible to concentrate research efforts on the reversion of affected tissues to a healthier condition more characteristic of younger humans. GHK gene studies have increasingly led to the conclusion that the conditions and diseases of aging cannot be scientifically treated without understanding the extensive changes in overall gene activity during aging.
There are three sources of evidence on GHK actions:
A. The best data is in vivo mammalian data, including human clinical studies. As reviewed in this paper, these studies give overwhelming evidence of GHK's effects on cells and tissue growth, as well as anti-cancer, anti-oxidant, wound-healing, anti-inflammation, anti-pain, anti-anxiety and skin regeneration actions. B.
A second form of data is in vitro cell culture and organ culture results. Culture results give evidence about the effect of GHK on cellular production of collagen and other structural proteins, the effect on stem cell function, the recovery of cellular function after anticancer radiation or ultraviolet radiation, and sensitivity of cells to oxidative molecules. C.
A third source of data is in Human Gene expression. Data analysis found that GHK induces a 50% or greater (plus or minus) change of expression in 31.2% of human genes, affecting genes linked to multiple biochemical pathways in many organs and tissue, including the nervous system.
Many studies highlight gene expression effects of various molecules. Given today's advances in computer modeling, it is not that difficult to find substances which affect gene expression in one way or another. However, in most cases, computer-based predictions do not have the same supporting evidence of in vivo and in vitro laboratory data as GHK has. Also, in many cases, the safety and cost of the proposed treatments are a big concern. GHK is safe, inexpensive, and can be used in humans today.
The future research should be focused on further making sense of the very extensive gene data, which has to be paralleled with laboratory and clinical studies. GHK has a wealth of biological data in the areas of wound healing, hair and skin regeneration, intestinal tract and bone repair. However, there is a surprising lack of GHK research in the area of neurodegeneration and cognitive health. We hope that our gene data will encourage researchers to take a better look at biological actions and significance of GHK in connection with cognitive health and nervous system function.
The best administration method, in our opinion, would be GHK-Cu incorporated into liposomes, then administered as an enteric capsule for oral use. A dosage of 10 mgs per dose would be a good starting point, at least for safety studies, but inducing positive actions will most likely require a higher dosage.
